Evaluating an Interactive Digital Toolkit for Women's PrEP Implementation
This study is testing an Interactive Digital PrEP Toolkit to help cisgender women in Alabama and Mississippi learn about and access PrEP (pre-exposure prophylaxis), a medication that prevents HIV infection. The toolkit provides education, information on PrEP options (pills, injections), and testimonials. Researchers want to see if the toolkit is easy to use, if people complete it quickly, and if it encourages more women to start PrEP. You might be able to join if you are an HIV-negative cisgender woman, 18 or older, English-speaking, and sexually active. The study is currently unclear on its recruitment status and plans to enroll up to 125 women.
- Study design
- This is an interventional study involving up to 125 cisgender women. It is not specified if it is randomized or blinded.
- What's involved
- You will use the Digital PrEP Toolkit on a tablet at a clinic and answer questions about your HIV knowledge before and after using it. This will occur over a 12-month enrollment period, with follow-up for 3 months after that.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed for 3 months after the end of the 12-month enrollment period, for a total of 15 months.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Evaluating an Interactive Digital Toolkit for Women's PrEP Implementation
At a glance
Conditions
Where it's being run
4 sites across 2 statesStudy leadership
- Mirjam-Colette Kempf, PhD, MPH · PRINCIPAL_INVESTIGATOR · University of Alabama at Birmingham
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Feasibility: Toolkit completion rateThroughout 12-month enrollment period
Percentage of eligible women who complete the PrEP Toolkit out of women screened and enrolled
- Feasibility: Toolkit Completion TimeThroughout 12-month enrollment period
Average time needed to complete PrEP Toolkit activities
- Acceptability: Participant SatisfactionFrom enrollment to the end of the 3 month follow-up period at 15-months
Participant satisfaction will be assessed using a study-specific satisfaction questionnaire measuring perceived value and ease of use of the Digital PrEP Toolkit. The questionnaire includes Likert-scale items (range: 1-5, with higher scores indicating greater satisfaction) evaluating Toolkit usability, perceived usefulness, and overall satisfaction.
- Preliminary Efficacy: Participant PrEP UptakeFrom enrollment to the end of the 3 month follow up period at 15-months
Proportion of eligible women who initiate PrEP after using the PrEP Toolkit to eligible clients screened
- Preliminary Efficacy: Clinic-level PrEP uptakeFrom enrollment to the end of the 3 month follow up period at 15-months
Comparison of PrEP uptake rates up to 12-months prior to study start to PrEP uptake rates during the approximately 12-month study enrollment period among eligible women at the partnering clinic sites
- Preliminary Efficacy: HIV and PrEP KnowledgeFrom enrollment to the end of the 3 month follow up period at 15-months
Changes in HIV and PrEP knowledge will be assessed using an adapted version of the updated HIV Knowledge Questionnaire (range: 0-31, with higher scores indicating greater knowledge).